In a recent decision, the National Pharmaceutical Pricing Authority (NPPA) has withdrawn its guidelines for price control on drugs which do not fall under the National List of Essential Medicines (NLEM). This move is said to have an impact on 108 non-essential drugs. These guidelines were earlier issued under its Drug Prices Control Order which empowered NPPA to control prices of drugs not falling under NLEM also. Many are concerned that this might lead to a steep price rise of certain drugs in India, some of which are required in treatment of serious medical conditions, as the pharma companies would be now free to fix their prices on these drugs. Watch Sarokaar with eminent panellists discussing the issue from various perspectives. Guests: Dr. Sambit Patra (National Spokesperson, BJP) ; Amitabh Guha (National Convener, Jan Swasthya Abhiyan ) ; M L Sharma (Advocate and Petitioner​) ; D G Shah (Secretary General, Indian Pharmaceutical Alliance) ; Dr. Vikas Vajpayee (Assistant Professor, Centre for Social Medicine and Community Health, JNU) Anchor: Amrita Rai

Be the first to comment